Mylan CEO: We took care of the EpiPen problem

Mylan CEO Heather Bresch on the EpiPen controversy, the health care industry and efforts to lower drug prices and improve the drug approval process.

(Source: Fox Business TV, January 9, 2018 at 10:50AM)

Recommended posts powered by Google